Literature DB >> 324772

Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.

B G Hansson, J F Dymling, P Manhem, B Hökfelt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 324772     DOI： 10.1007/bf00607672

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  49 in total

1.  Effect of insulin on urinary excretion of adrenalin and noradrenalin; studies in ten healthy subjects and in six cases of acromegaly.

Authors:  U S VON EULER; R LUFT
Journal:  Metabolism       Date:  1952-11       Impact factor: 8.694

2.  Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work.

Authors:  G Johnsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia.

Authors:  E A Abramson; R A Arky; K A Woeber
Journal:  Lancet       Date:  1966-12-24       Impact factor: 79.321

5.  Effects of infusion of catecholamines and angiotensin II on renin release in anesthetized dogs.

Authors:  R L Wathen; W S Kingsbury; D A Stouder; E G Schneider; H H Rostorfer
Journal:  Am J Physiol       Date:  1965-11

6.  Effect of practolol on blood pressure and renin release in man.

Authors:  M D Esler
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

7.  A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Normal resting human plasma levels.

Authors:  K Engelman; B Portnoy
Journal:  Circ Res       Date:  1970-01       Impact factor: 17.367

8.  Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness.

Authors:  M D Esler; P J Nestel
Journal:  Br Heart J       Date:  1973-05

9.  Neural stimulation of release of renin.

Authors:  R D Bunag; I H Page; J W McCubbin
Journal:  Circ Res       Date:  1966-10       Impact factor: 17.367

10.  Plasma catecholamines and renin activity in response to exercise in patients with essential hypertension.

Authors:  J Chodakowska; K Nazar; B Wocial; M Jarecki; B Skórka
Journal:  Clin Sci Mol Med       Date:  1975-11
View more
  5 in total

Review 1.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

2.  Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.

Authors:  G Planz; R Planz
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

3.  Unchanged peripheral sympathetic activity following withdrawal of chronic metoprolol treatment. A study of noradrenaline concentrations and kinetics in plasma.

Authors:  G Olsson; M Daleskog; P Hjemdahl; N Rehnqvist
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

4.  Response of blood pressure and plasma norepinephrine to propranolol, metoprolol and clonidine during isometric and dynamic exercise in hypertensive patients.

Authors:  K Virtanen; J Jänne; M H Frick
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Effect of metoprolol on blood glycerol, free fatty acids, triglycerides and glucose in relation to plasma catecholamines in hypertensive patients at rest and following submaximal work.

Authors:  A Nilsson; B G Hansson; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.